-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
TherapeuticsMD, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- TherapeuticsMD, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$1.09M, a 54.8% increase year-over-year.
- TherapeuticsMD, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$6.09M, a 114% decline year-over-year.
- TherapeuticsMD, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$10.3M, a 109% decline from 2022.
- TherapeuticsMD, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $112M.
- TherapeuticsMD, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$172M, a 6.05% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)